The company mainly produces pharmaceutical intermediates. At present, 300 tons/year sulfamethoxazole, 600 tons/year aminotoluenic acid, 240 tons/year tranexamic acid, the three products in hemolytic streptococcus, dysentery bacillus inhibit and..
Relevance: 8.590922